Why CRISPR Will Be at the Forefront of AI
Kelly ETFs Founder & CEO Kevin Kelly joins Jill Malandrino on Nasdaq #TradeTalks to discuss why CRISPR will be at the forefront of AI, imaging, and sequencing on top of being commercialized. $XDNA
Kelly ETFs Founder & CEO Kevin Kelly joins Jill Malandrino on Nasdaq #TradeTalks to discuss why CRISPR will be at the forefront of AI, imaging, and sequencing on top of being commercialized. $XDNA
Пікірлер: 13
IBD is a corporate bond ETF. Intellia is NTLA...
This is the biggest news ever for people who suffer from sickle cell and certain inherited diseases. I just wish they could give people and idea of where they should go to receive such treatment🎉😂🎉8
This is excellent news!!!
One and done treatment? Big farma does not like this idea.
98 views in 2 days. Waste of time.
@clintbailo6058
Жыл бұрын
Tells you why very few people are rich
Please get better audio
Hilarious. Trying to follow ARK's marketing scheme
@sweetpotatogreens7491
11 ай бұрын
what is ARK?
@lassataest5604
11 ай бұрын
@@sweetpotatogreens7491 ARK ETF's
@MooseMeus
7 ай бұрын
@@sweetpotatogreens7491 an asset management company run by cathie wood.